Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) Price Target at $29.11

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been given an average rating of "Buy" by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $24.67.

Several equities analysts have recently issued reports on ASPN shares. Barclays reduced their target price on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Saturday, February 8th. Roth Mkm dropped their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Friday. Canaccord Genuity Group reduced their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Millennium Management LLC increased its holdings in shares of Aspen Aerogels by 4,757.8% during the fourth quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock valued at $19,270,000 after acquiring an additional 1,588,632 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in Aspen Aerogels during the 4th quarter valued at about $13,122,000. Alyeska Investment Group L.P. bought a new stake in Aspen Aerogels during the 4th quarter valued at about $9,504,000. Dendur Capital LP purchased a new position in Aspen Aerogels in the fourth quarter worth about $9,207,000. Finally, FMR LLC lifted its stake in shares of Aspen Aerogels by 23.6% in the third quarter. FMR LLC now owns 4,050,896 shares of the construction company's stock worth $112,169,000 after buying an additional 773,647 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Trading Down 3.7 %

ASPN traded down $0.33 during trading on Friday, hitting $8.67. 5,245,173 shares of the stock traded hands, compared to its average volume of 1,390,847. The firm has a market capitalization of $711.05 million, a P/E ratio of 867.47 and a beta of 2.14. Aspen Aerogels has a 12-month low of $8.25 and a 12-month high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm has a 50-day moving average of $12.17 and a 200 day moving average of $18.45.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Equities research analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.